Medigen Vaccine Biologics Corporation (TPEX: 6547)
Taiwan
· Delayed Price · Currency is TWD 43.80
-0.50 (-1.13%)
Oct 7, 2024, 9:51 AM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 14.51 billion as of October 11, 2024. Its market cap has decreased by -36.86% in one year.
Market Cap
14.51B
Enterprise Value
13.02B
Revenue
623.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.80
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 14.51B, an increase of 411.90%. That is a compound annual growth rate of 19.45%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition